SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,075-2.6%12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (145)4/19/1998 11:05:00 PM
From: kas1  Read Replies (2) of 641
 
anyone else think that pfe is gaining too much market value on a $9 erection pill? imho, one of the enticing things about drug companies is that they are resistant to economic downturns -- but that is no longer the case with some of these 'elective' drugs (evista may fit the bill here too?).

imho, zyprexa is the (unpublicized) blockbuster here... and, as is usually the case with psych drugs, fewer cases of schizophrenia will go undiagnosed once patients & doctors know that there's a new more effective remedy --like what prozac (and ssri's in general) did to undiagnosed depression when treatment for depression no longer meant electroshock, tricyclics, etc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext